About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Lymphoma Clinical Trials in Washington | 859 Studies

Clinical Trials LymphomaWashington

Lymphoma Clinical Trials in Washington

Find 859 clinical trials for lymphoma near Washington. Connect with research centers in your area.

All Lymphoma trials nationwide All trials in Washington

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 81-100 of 859 trials

CompletedA Phase 1, Open-label Trial of Oral Azacitidine (CC-486) Plus RCHOP in Subjects With Large B-Cell Lymphoma or Follicular Lymphoma or Transformed LymphomaThe goal of the study is to identify a dose and schedule of CC-486 that can be safely administered with R-CHOP.NCT02343536·Tampa, Florida and 6 others TerminatedPegylated Liposomal Doxorubicin Containing Chemotherapy in the Treatment of Older Non-Hodgkin's Lymphoma PatientsCurrently there is no one standard of care for older patients with Non-Hodgkin's Lymphoma (NHL).NCT00120198·Oxnard, California and 4 others Active not recruitingManaging Pain and Symptom Burden Caused by Chemotherapy in People With Myeloma or LymphomaThe purpose of this study is to find out whether acupuncture treatments can reduce the need for opioid medication when managing pain caused by chemotherapy.NCT04459416·New York, New York and 1 other

Lymphoma Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

TerminatedA Phase 1b/2 Safety and Tolerability Study of MEDI6469 in Combination With Therapeutic Immune Agents or Monoclonal AntibodiesThe main purpose of this study is to determine the best dose of MEDI6469 that is safe and tolerable when given as monotherapy and in combination with tremelimumab, MEDI4736…NCT02205333·Scottsdale, Arizona and 12 others

CompletedCombination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk B Acute Lymphoblastic Leukemia and Ph-Like TKI Sensitive MutationsThis randomized phase III trial studies how well combination chemotherapy works in treating young patients with newly diagnosed B acute lymphoblastic leukemia that is likely to…NCT02883049·Birmingham, Alabama and 238 others

Active not recruitingAn Open-label, Phase 2 Study of ACP-196 (Acalabrutinib) in Subjects With Mantle Cell LymphomaThe purpose of this study is to characterize the safety and efficacy profile of ACP-196 (acalabrutinib) in subjects with relapsed or refractory Mantle Cell Lymphoma (MCL).NCT02213926·Tampa, Florida and 57 others

TerminatedFT516 in Subjects With Advanced Hematologic MalignanciesThis is a Phase 1/1b dose-finding study of FT516 as monotherapy in acute myeloid leukemia (AML) and in combination with CD20 directed monoclonal antibodies in B-cell lymphoma.NCT04023071·Phoenix, Arizona and 6 others

CompletedValacyclovir in Preventing Cytomegalovirus Infection in Patients Who Are Undergoing Donor Stem Cell TransplantationRATIONALE: Antivirals such as valacyclovir act against viruses and may be effective in preventing cytomegalovirus.NCT00045292·Duarte, California and 5 others

CompletedNKTR-255 in Combination With CAR-T Cell Therapy for the Treatment of Relapsed or Refractory Large B-cell LymphomaThis phase Ib trial studies the effects of NKTR-255 in combination with chimeric antigen (CAR)-T cell therapy and to see how well they work in treating patients with large B-cell…NCT05359211·Seattle, Washington

TerminatedPhase I/II Study of Abraxane in Recurrent and Refractory LymphomaThis phase I/II trial studies the side effects, maximum tolerated dose, and effectiveness of paclitaxel albumin-stabilized nanoparticle formulation (nab-paclitaxel) in treating…NCT01555853·St Louis, Missouri and 1 other

CompletedA Study of Oral LOXO-305 in Patients With Previously Treated CLL/SLL or NHLThis is an open-label, multi-center Phase 1/2 study of oral LOXO-305 (pirtobrutinib) in patients with CLL/SLL and NHL who have failed or are intolerant to standard of care.NCT03740529·Scottsdale, Arizona and 55 others

CompletedIodine I 131 Tositumomab Followed by Autologous Stem Cell Transplantation in Treating Older Patients With Relapsed or Refractory Non-Hodgkin's LymphomaRATIONALE: Radiolabeled monoclonal antibodies, such as iodine I 131 tositumomab, can locate cancer cells and deliver radioactive cancer-killing substances to them without harming…NCT00073931·Seattle, Washington

CompletedNon-inferiority Study of XM02 Filgrastim (Granix) and Filgrastim (Neupogen) in Combination With Plerixafor for Autologous Stem Cell Mobilization in Patients With Multiple Myeloma or Non-Hodgkin LymphomaThis study will compare the results of stem cell mobilization using drugs called filgrastim (Neupogen) and plerixafor with the results of stem cell mobilization using drugs called…NCT02098109·St Louis, Missouri

CompletedStudy of Tazemetostat as Single Agent in Solid Tumors or B-cell Lymphomas and in Combination With Prednisolone in DLBCLThis is an open-label, multicenter, Phase 1/2 study of tazemetostat as a single agent in subjects with advanced solid tumors or with B-cell lymphomas and tazemetostat in…NCT01897571·Birmingham, Alabama and 51 others

RecruitingA Clinical Trial to Evaluate Efficacy, Safety, and Pharmacokinetics of Gamunex in Participants With Secondary Antibody Deficiency Associated With Chronic Lymphocytic Leukemia, Multiple Myeloma, or Non-Hodgkin LymphomaThe main goal of this study is to show that people with certain immune problems (from Chronic Lymphocytic Leukemia, Multiple Myeloma, or Non-Hodgkin Lymphoma) get fewer serious…NCT07582432·St. Petersburg, Florida and 4 others

TerminatedSafety, Pharmacodynamics, Pharmacokinetics, and Efficacy of GS-9901 in Adults With Relapsed or Refractory Follicular Lymphoma, Marginal Zone Lymphoma, Chronic Lymphocytic Leukemia, or Small Lymphocytic LymphomaThis study will evaluate the safety and tolerability of GS-9901 monotherapy in adults with follicular lymphoma (FL), marginal zone lymphoma (MZL), chronic lymphocytic leukemia…NCT02258555·Duarte, California and 5 others

WithdrawnGenetically Modified Peripheral Blood Stem Cell Transplant in Treating Patients With HIV-Associated Non-Hodgkin or Hodgkin LymphomaThis clinical trial studies genetically modified peripheral blood stem cell transplant in treating patients with HIV-associated non-Hodgkin or Hodgkin lymphoma.NCT01769911·Seattle, Washington

TerminatedAn Extension Study for Subjects Who Are Deriving Benefit With Idelalisib (GS-1101; CAL-101) Following Completion of a Prior Idelalisib StudyThis is a long-term safety extension study of idelalisib (GS-1101; CAL-101) in patients with hematologic malignancies who complete other idelalisib studies.NCT01090414·Huntsville, Alabama and 17 others

Active not recruitingMosunetuzumab Consolidation Therapy After autoSCT in r/r Aggressive B Cell LymphomaThis phase 1 pilot study examines the feasibility and safety of mosunetuzumab after autologous stem cell transplant for patients with aggressive B cell lymphomas.NCT05412290·St Louis, Missouri

TerminatedA Study of BGB-21447, a Bcl-2 Inhibitor, in Mature B-Cell MalignanciesThis study is testing the safety and tolerability of BGB-21447 monotherapy in participants with relapsed or refractory (R/R) non-Hodgkin lymphoma (NHL) and chronic lymphocytic…NCT05828589·Washington D.C., District of Columbia and 27 others

PreviousPage 5 of 43Next

Other Conditions in Washington

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia